Literature DB >> 7076681

Thrombin-catalyzed activation of human coagulation factor V.

K Suzuki, B Dahlbäck, J Stenflo.   

Abstract

Human coagulation factor V was purified from freshly frozen plasma by a method that gave high yields of single chain factor V. The purified protein has an Mr = 330,000 and consists of a single polypeptide chain with the following NH2-terminal sequence: Ala-Gln-Leu-Gly-Gln-Phe-Tyr-Val. Limited proteolysis of factor V by thrombin led to formation of factor Va which has a cofactor activity 25- to 30-fold that of factor V. Two intermediates and four end products were formed in the course of activation. From the NH2 terminus of factor V the end products are termed (apparent molecular weights in parentheses), fragment D (105,000), E (71,000), C1 (150,000), and F1F2 (71-74,000). The carboxyl-terminal fragment F1F2 is a doublet presumably resulting from cleavage of one of two approximately equally sensitive bonds. The end products but not the intermediates resemble those obtained on thrombin activation of bovine factor V, indicating a different order of peptide bond cleavages. The thrombin-catalyzed activation of purified factor V resembles the activation of factor V in plasma as judged from the activation pattern of a 125I-labeled factor V tracer in coagulating plasma. Fragments D and F1F2 are held together by noncovalent interactions and constitute the biologically active factor V molecule as judged from reconstitution experiments utilizing the isolated fragments. The two fragments (E and C1), derived from the interior of the molecule, are activation peptides.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.

Authors:  X J Yang; M A Blajchman; S Craven; L M Smith; N Anvari; F A Ofosu
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Electron microscopy of human factor V and factor VIII: correlation of morphology with domain structure and localization of factor V activation fragments.

Authors:  W E Fowler; P J Fay; D S Arvan; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Authors:  Matthew W Bunce; Mettine H A Bos; Sriram Krishnaswamy; Rodney M Camire
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

5.  2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-23       Impact factor: 8.311

6.  Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

7.  Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex.

Authors:  H Deguchi; H Takeya; E C Gabazza; J Nishioka; K Suzuki
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

8.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.

Authors:  W H Kane; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

10.  The role of thrombin exosites I and II in the activation of human coagulation factor V.

Authors:  Kenneth Segers; Björn Dahlbäck; Paul E Bock; Guido Tans; Jan Rosing; Gerry A F Nicolaes
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.